![](https://www.diabetesnews.com/wp-content/uploads/2012/04/VariousPills.0-150x150.jpg)
In treating type 2 diabetes, the first-line option is typically metformin. When metformin alone isn’t achieving the patient’s goals, the second and third-line options for pharmacological treatment are complex, with multiple drug classes and multiple drugs within those classes. A new analysis looks at the pros and cons of some key combinations. Read more